Maxcyte (DI) (MXCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Aug 2021 07:00 AM
RNS
License with Sana Biotechnology
05 Aug 2021 04:05 PM
RNS
Amendments to Bylaws
03 Aug 2021 03:51 PM
RNS
Closing of Offering
02 Aug 2021 07:00 AM
RNS
Full Exercise of Over-Allotment Option
30 Jul 2021 04:43 PM
RNS
Second Price Monitoring Extn
30 Jul 2021 04:36 PM
RNS
Price Monitoring Extension
30 Jul 2021 07:00 AM
RNS
Pricing of Offering and Approval to List on Nasdaq
26 Jul 2021 11:14 AM
RNS
Launch of Offering and Application to List
19 Jul 2021 12:30 PM
RNS
Termination of DI facility and transition to CDI
12 Jul 2021 07:00 AM
RNS
S-1 Financial information & Directorate Change
12 Jul 2021 07:00 AM
RNS
Public Filing of Registration Statement with SEC
06 Jul 2021 05:36 PM
RNS
Result of Special Meeting
16 Jun 2021 07:01 AM
RNS
Publication of Annual Report and Accounts
16 Jun 2021 07:00 AM
RNS
Stockholder Circular and Notice of Special Meeting
15 Jun 2021 07:00 AM
RNS
Maxcyte Appoints Two New Non-Executive Directors
02 Jun 2021 09:18 AM
RNS
Total Voting Rights
25 May 2021 07:00 AM
RNS
Signing of Strategic Platform Licence
14 May 2021 07:00 AM
RNS
Proposed Dual-Listing on Nasdaq
13 May 2021 07:00 AM
RNS
Consolidation of Trading Lines
20 Apr 2021 07:00 AM
RNS
Full Year Results
15 Apr 2021 07:00 AM
RNS
Notice of Full Year Results
01 Apr 2021 07:00 AM
RNS
Total Voting Rights
11 Mar 2021 03:01 PM
RNS
Holding(s) in Company
03 Mar 2021 07:00 AM
RNS
Total Voting Rights
23 Feb 2021 07:00 AM
RNS
Participation in Upcoming Investor Conferences
19 Feb 2021 07:00 AM
RNS
Director Dealings and Issue of Equity
17 Feb 2021 05:44 PM
RNS
Grant of Options
15 Feb 2021 04:32 PM
RNS
Holding(s) in Company
12 Feb 2021 01:59 PM
RNS
Holding(s) in Company
08 Feb 2021 02:59 PM
RNS
Holding(s) in Company
05 Feb 2021 09:01 AM
RNS
Price Monitoring Extension
04 Feb 2021 07:00 AM
RNS
Director Dealings and Issue of Equity
04 Feb 2021 07:00 AM
RNS
CORRECTION: MaxCyte Announces £40m Subscription
03 Feb 2021 04:36 PM
RNS
MaxCyte Announces £40 million Subscription
03 Feb 2021 04:35 PM
RNS
Appointment of Joint Corporate Broker
21 Jan 2021 02:49 PM
RNS
Increase to Block Listing
20 Jan 2021 07:00 AM
RNS
Trading Update
11 Jan 2021 07:00 AM
RNS
Myeloid Therapeutics Clinical & Commercial License
23 Dec 2020 07:00 AM
RNS
Trading Update
09 Nov 2020 01:00 PM
RNS
CARMA Cell Therapies at SITC 2020
09 Nov 2020 07:00 AM
RNS
Presentations at Upcoming Virtual IR Conferences
02 Nov 2020 03:52 PM
RNS
Result of AGM
22 Oct 2020 06:22 PM
RNS
Disclosure of Remuneration for Non-Audit Services
14 Oct 2020 07:00 AM
RNS
Notification of AGM and Audit Declaration
13 Oct 2020 07:00 AM
RNS
MaxCyte announces leadership appointments
01 Oct 2020 07:00 AM
RNS
Director/PDMR Shareholding
21 Sep 2020 07:00 AM
RNS
Results for the Six Months ended 30 June 2020
10 Sep 2020 01:42 PM
RNS
Grant of options
10 Sep 2020 07:00 AM
RNS
HC Wainright & Co Virtual Conference Presentation
09 Sep 2020 07:00 AM
RNS
Appointment of Amanda L. Murphy as CFO
UK 100

Latest directors dealings